Cen Chang
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
Papers in
- Rheumatology 21
- Rheumatoid Arthritis Research and Therapies 17
- Systemic Lupus Erythematosus Research 4
- Hematology 13
- Autoimmune and Inflammatory Disorders Research 12
Cen Chang
33 papers receiving 548 citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Rheumatology 188
- Nephrology 59
- Hematology 68
- Cancer Research 81
- Immunology 111
Countries citing papers authored by Cen Chang
This map shows the geographic impact of Cen Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cen Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cen Chang more than expected).
Fields of papers citing papers by Cen Chang
This network shows the impact of papers produced by Cen Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cen Chang. The network helps show where Cen Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cen Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 10 | |
| 8 | Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts Hit paper breakdown → | 2024 | 65 |
| 9 | 2024 | 1 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 12 | |
| 14 | 2023 | 30 | |
| 15 | 2023 | 9 | |
| 16 | 2022 | 33 | |
| 17 | 2022 | 11 | |
| 18 | 2022 | 17 | |
| 19 | 2022 | 22 | |
| 20 | 2021 | 9 |
About Cen Chang
Cen Chang is a scholar working on Rheumatology, Hematology, Hepatology, Genetics and Complementary and alternative medicine, having authored 37 papers that have together received 552 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (17 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Lymphoma Diagnosis and Treatment (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer-related molecular mechanisms research (4 papers), Hepatitis C virus research (4 papers) and Systemic Lupus Erythematosus Research (4 papers). The work is most often cited by research in Rheumatology (188 citations), Nephrology (59 citations), Hematology (68 citations), Cancer Research (81 citations) and Immunology (111 citations). Cen Chang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shicheng Guo, Lingxia Xu, Kai Wei, Yiming Shi, Jianan Zhao, Linshuai Xu, Yehua Jin, Ping Jiang, Dongyi He and Dongyi He. Their work appears in journals such as Frontiers in Immunology, Frontiers in Pharmacology, International Immunopharmacology, Frontiers in Genetics and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.